NO307831B1 - 3-indolylpiperidiner, farmasøytiske preparater som inneholder disse, og anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

3-indolylpiperidiner, farmasøytiske preparater som inneholder disse, og anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number
NO307831B1
NO307831B1 NO951529A NO951529A NO307831B1 NO 307831 B1 NO307831 B1 NO 307831B1 NO 951529 A NO951529 A NO 951529A NO 951529 A NO951529 A NO 951529A NO 307831 B1 NO307831 B1 NO 307831B1
Authority
NO
Norway
Prior art keywords
indolylpiperidines
compounds
manufacture
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO951529A
Other languages
English (en)
Norwegian (no)
Other versions
NO951529L (no
NO951529D0 (no
Inventor
Henning Boettcher
Joachim Morz
Christoph Seyfried
Hartmut Greiner
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO951529D0 publication Critical patent/NO951529D0/no
Publication of NO951529L publication Critical patent/NO951529L/no
Publication of NO307831B1 publication Critical patent/NO307831B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO951529A 1994-04-22 1995-04-21 3-indolylpiperidiner, farmasøytiske preparater som inneholder disse, og anvendelse av forbindelsene til fremstilling av legemidler NO307831B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4414113A DE4414113A1 (de) 1994-04-22 1994-04-22 3-Indolylpiperidine

Publications (3)

Publication Number Publication Date
NO951529D0 NO951529D0 (no) 1995-04-21
NO951529L NO951529L (no) 1995-10-23
NO307831B1 true NO307831B1 (no) 2000-06-05

Family

ID=6516183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951529A NO307831B1 (no) 1994-04-22 1995-04-21 3-indolylpiperidiner, farmasøytiske preparater som inneholder disse, og anvendelse av forbindelsene til fremstilling av legemidler

Country Status (20)

Country Link
US (1) US5693655A (es)
EP (1) EP0683166B1 (es)
JP (1) JPH07291969A (es)
KR (1) KR100361950B1 (es)
CN (1) CN1047385C (es)
AT (1) ATE172730T1 (es)
AU (1) AU697749B2 (es)
CA (1) CA2147451C (es)
CZ (1) CZ285369B6 (es)
DE (2) DE4414113A1 (es)
DK (1) DK0683166T3 (es)
ES (1) ES2125508T3 (es)
HU (1) HUT74096A (es)
NO (1) NO307831B1 (es)
PL (1) PL180781B1 (es)
RU (1) RU2151148C1 (es)
SK (1) SK280881B6 (es)
TW (1) TW401416B (es)
UA (1) UA41333C2 (es)
ZA (1) ZA953260B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
GB9523462D0 (en) * 1995-11-16 1996-01-17 Merck Sharp & Dohme Therapeutic agents
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
CA2297825C (en) 1997-07-25 2006-03-14 H. Lundbeck A/S Indole and 2,3-dihydroindole derivatives, their preparation and use
ID23803A (id) * 1997-08-15 2000-05-11 Pfizer Prod Inc Turunan-turunan 2-(4-aril atau heteroaril-piperazin-1-ilmetil)-1h-indola
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AU738777B2 (en) * 1998-03-18 2001-09-27 Nihon Nohyaku Co., Ltd. Aromaheterocyclic derivatives
CN1166665C (zh) * 1998-03-19 2004-09-15 日本农药株式会社 芳基哌啶衍生物及其用途
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
AU765317C (en) * 1998-06-19 2004-05-20 H. Lundbeck A/S 4,5,6 and 7-indole and indoline derivatives, their preparation and use
BR9911843A (pt) 1998-06-19 2001-03-20 Lundbeck & Co As H 4 5 6 7-indol e derivados de indolina, preparação e utilização dos mesmos
US6066637A (en) * 1998-06-19 2000-05-23 American Home Products Corporation Indolyl derivatives as serotonergic agents
AR020773A1 (es) * 1998-10-16 2002-05-29 Duphar Int Res Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
CA2373855A1 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
SI1212320T1 (en) 1999-08-23 2005-10-31 Solvay Pharmaceuticals B.V. Phenylpiperazines as serotonin reuptake inhibitors
US6806275B2 (en) 2000-09-13 2004-10-19 Nihon Nohyaku Co., Ltd. Arylpiperidine derivatives and use thereof
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
WO2003010169A1 (en) * 2001-07-25 2003-02-06 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7235569B2 (en) * 2003-05-02 2007-06-26 Wyeth Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2675801A (en) * 1954-04-20 Intramedbllary nail
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
GB2044254B (en) 1979-01-26 1983-01-26 Wyeth John & Brother Ltd Piperidine derivatives
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8531665D0 (en) * 1985-12-23 1986-02-05 Wyeth John & Brother Ltd Indole derivatives
JP2860688B2 (ja) * 1990-03-14 1999-02-24 第一製薬株式会社 インドール誘導体
FR2675801A1 (fr) 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
KR102044254B1 (ko) * 2018-01-18 2019-11-13 (주)우신에이펙 배광제어가 가능한 led 탐조등

Also Published As

Publication number Publication date
UA41333C2 (uk) 2001-09-17
AU1648895A (en) 1995-11-02
KR950032176A (ko) 1995-12-20
PL308287A1 (en) 1995-10-30
DK0683166T3 (da) 1999-07-12
SK50895A3 (en) 1995-11-08
EP0683166A1 (de) 1995-11-22
CN1114651A (zh) 1996-01-10
US5693655A (en) 1997-12-02
NO951529L (no) 1995-10-23
HU9501139D0 (en) 1995-06-28
KR100361950B1 (ko) 2003-02-05
CZ103595A3 (en) 1995-12-13
DE4414113A1 (de) 1995-10-26
HUT74096A (en) 1996-11-28
CN1047385C (zh) 1999-12-15
RU95106675A (ru) 1997-03-20
JPH07291969A (ja) 1995-11-07
EP0683166B1 (de) 1998-10-28
RU2151148C1 (ru) 2000-06-20
ES2125508T3 (es) 1999-03-01
CA2147451C (en) 2006-03-28
CZ285369B6 (cs) 1999-07-14
ATE172730T1 (de) 1998-11-15
NO951529D0 (no) 1995-04-21
AU697749B2 (en) 1998-10-15
SK280881B6 (sk) 2000-08-14
ZA953260B (en) 1996-01-09
DE59504032D1 (de) 1998-12-03
CA2147451A1 (en) 1995-10-23
TW401416B (en) 2000-08-11
PL180781B1 (pl) 2001-04-30

Similar Documents

Publication Publication Date Title
NO307831B1 (no) 3-indolylpiperidiner, farmasøytiske preparater som inneholder disse, og anvendelse av forbindelsene til fremstilling av legemidler
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NZ508923A (en) N-phenyl-1-Methyl-2-oxo-quinoline-3-carboxamide derivatives, pharmaceuticals thereof and their use in therapy
DK0633259T3 (da) Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
ATE152448T1 (de) Heterozyklische alkylamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
DK0386452T3 (da) Diphenylheteroalkylderivater, fremgangsmåde til fremstilling heraf og lægemidler og kosmetika indeholdende disse
NO940144L (no) 2-(4-hydroksypiperidino)1-alkanolderivater som antiiskemiske midler
IT1264857B1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
DK0641759T3 (da) Anvendelse af aromatiske carboxylsyrederivater til fremstilling af farmaceutiske præparater
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO301767B1 (no) Salt av clavulansyre
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU6602394A (en) New alpha-amino acid compounds, a process for the preparation thereof and pharmaceutical compositions containing them
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO884005L (no) Fluorerte derivater av aminosyrer saerlig for bruk som overflateaktive midler.
BR9407654A (pt) Novos compostos aminoesteróides contendo uretano
DK0627916T3 (da) Farmaceutisk præparat, anvendeligt som analgetikum og indeholdende (R)-2-(3-benzoylphenyl)propionsyre
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
NO304025B1 (no) Heteroarenylpiperaziner, farmas°ytiske preparater inneholdende slike forbindelser og anvendelse derav som legemidler
DK0463139T3 (da) 2,13-disubstituerede ergoliner, deres fremstilling og deres anvendelse i lægemidler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees